Retroperitoneal lymphadenectomy remains the treatment of choice in nonseminomatous germ cell tumors.
Graham
S D
SD
Department of Surgery, Emory University School of Medicine, Atlanta, GA.
D000328:Adult; D014408:Biomarkers, Tumor / Q000097:blood; D006801:Humans; D008197:Lymph Node Excision / Q000191:economics / Q000379:methods* / Q000401:mortality; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000453:epidemiology; D009373:Neoplasms, Germ Cell and Embryonal / Q000097:blood / Q000175:diagnosis / Q000401:mortality / Q000601:surgery*; D010349:Patient Compliance; D011159:Population Surveillance; D012187:Retroperitoneal Space; D015996:Survival Rate; D013736:Testicular Neoplasms / Q000097:blood / Q000175:diagnosis / Q000401:mortality / Q000523:psychology / Q000601:surgery*; D016896:Treatment Outcome
D014408:Biomarkers, Tumor